Conventional brachytherapy has always been recognised as an excellent way to deliver a high dose of radiation to the heart of a tumour but has had the disadvantage that it takes a long time and involves risk of radiation exposure. Recent developments in afterloading technology and source design now make it possible to give a high dose of radiation in a verv short time without exposure hazard and with the possibility of optimising dose distribution. This multiauthor book reviews recent experience in this rapidly growing field and should be of interest to anyone who has just started or is about to start high dose rate (HDR) brachytherapy.
Those who search for guidance on dose and fractionation regimens are not going to find it. because with the exception of a few sites there is too little experience and insufficient follow-up on which to base advice.
HDR brachytherapy has an accepted role in the management of carcinoma of the bronchus and oesophagus because it allows rapid safe treatment that cannot readily be given in any other way. It It is a concern that a chapter on cancer and nutrition makes no mention of temporary total parenteral nutrition (TPN) and enteral feeding with PEG (percutaneous endoscopic gastrostomy) which have had a profound effect on patient management in the last few years. The patient problems' section is a little confusing: rather than re-examining general approaches to diagnosis and investigation often 'spot diagnoses' are mentioned and referral to specialists advised rather than working through logical management strategies. A glossary of terms and references for further reading would have been useful for the non-specialist. 'Learning points' boxes would allow quicker reference and improve the look of the book as would more imaginative (and preferably colour) illustrations.
In summary. it is difficult to identif) a target readership for this book, particularly with competing publications being more modern in approach and presentation. This book certainly fills a gap as endocrine oncology has tended to be considered as a Cinderella subject in the oncology field. although past oncologists who have looked after thyroid and endocrine cancer have included some most distinguished individuals. This is generally a most excellent and comprehensive book which covers best the expected areas. However. I did wonder whether it was really necessary to try and be all-embracing and include sections on prostate cancer. testis cancer. germ cell cancers and breast tumours. These chapters are really only superficially covered and might better have been omitted altogether and left to a general oncology textbook or a specialist book. Nevertheless, the overall impression is of an excellent reference book.
I have not attempted to review the entire book since it is some 800-odd pages in length and there are several areas that do not come into my clinical practice. such as pituitary tumours. I have therefore concentrated on the thyroid. adrenal. pancreatic and gastrointestinal endocrine cancers and the carcinoid tumours, which constitute at least twothirds of the content of the book.
Thyroid cancer management presents a well-balanced overview. putting forward both sides of the arguments in those areas where there are many and deep controversies. Occassionally the authors' individual prejudices are allowed to shine through, but nevertheless the balance is generally very well done. There are plenty of good illustrations. tables and graphs which are clear and easy to understand. The section is well referenced and very comprehensive.
Adrenal neoplasms are also covered in depth: particularly well covered is the area on the work-up and diagnosis of adrenal neoplasms. although the non-surgical management is rather poorer. and the coverage of treatment with radionuclides such as ['3 I]MIBG and chemotherapy is almost dismissive. It is perhaps unfortunate that an oncologist did not contribute to this chapter. Furthermore. there is no mention of the use of indium-labelled octreotide in the diagnostic section of neuroendocrine tumours. which may represent an American bias.
Again the section on the gastrointestinal and pancreatic neuroendocrine cancers is generally well done. although it is
